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Obtaining a measurement of cardiac output (Q) that is practical, accurate, non-invasive, continuous, and fully automated is highly desirable in clinical practice. 1 Indeed, monitoringQ is a mandatory part of haemodynamic goal-directed therapy, 2 where prompt implementation can improve outcomes in highrisk patients. 3 4 Currently, the clinical standard for measuringQ is bolus thermodilution (Q TD ). Unfortunately, the pulmonary artery catheter (PAC) required is invasive, with possibly lifethreatening complications. 5 6 The non-invasive Fick measurement ofQ (FickQ) 7 -10 applies respiratory manoeuvres to determineQ. However, despite its theoretical simplicity, FickQ has practical difficulties. All Fick Q methods require two measures of steady-state arterial PCO 2 (Pa CO 2 ) and CO 2 elimination (VCO 2 ) to calculateQ: the first is executed during a baseline period of stable ventilation and the second is executed after a perturbation in ventilation from the baseline state. In order to be valid, the second measurements must be obtained after the Pa CO 2 andVCO 2 have stabilized, but before the changes in Pa CO 2 re-circulate to the lung. As the re-circulation time is short compared with the time it takes for Pa CO 2 andVCO 2 to stabilize, it is impossible to obtain a valid second measurement because during this short time, equilibrium between the pulmonary capillaries and alveoli does not occur. 11 In addition, Pa CO 2 is estimated from end-tidal
). While PE ′ CO 2 can provide a suitable estimate of Pa CO 2 in healthy lungs, this approximation is not reliable where significant ventilation/perfusion (V/Q) inequalities exist. Lastly, FickQ methods measure only the portion ofQ that perfuses alveoli and participates in gas exchange. Blood flow through intrapulmonary shunts (Q s ) cannot be detected by FickQ.
We describe a novel method (Q IT ) that overcomes the re-circulation limitation of previous FickQ measures, using a series of short iterative tests. The reliability ofQ IT is enhanced by pairing it with our previously developed technique of sequential gas delivery (SGD), allowing precise measures oḟ VCO 2 and more definitive estimates of Pa CO 2 from PE ′ CO 2 .
However, like previous FickQ methods,Q IT does not measurė Q s . We present its theoretical derivation, a description of its implementation, and a proof-of-concept study comparingQ IT withQ TD in a porcine liver transplant model.
Methods

The Fick equations
FickQ is based on the mass balance principle: during anysteady state, the O 2 and CO 2 exchange between pulmonary capillary blood and alveolar air is equal to the gas exchange between alveolar air and the environment. CO 2 is used as a tracer because, unlike O 2 , the relationship between CO 2 tension and CO 2 content in whole blood is virtually linear. 12 As equation (1) shows,VCO 2 can be expressed in terms ofQ, the difference between mixed venous and arterial CO 2 tensions (P v CO 2 − Pa CO 2 ) and the slope of the CO 2 dissociation curve (S). 13 Non-invasive end-tidal
) usually substitutes for Pa CO 2 , ignoring any inequalities, which nevertheless can be quite significant [equation (2)].
For the differential Fick (DF) method, 13V CO 2 and PE ′ CO 2 are measured at baseline and during a reduction in alveolar ventilation (VA). Assuming CO 2 production remains constant during the test,VA reduction results in an increase in Pa CO 2 to a new steady state. The Fick mass balance equations for each of the baseline and test states are shown in equation (3a and b), where B and T superscripts refer to baseline and test states, respectively. Assuming P v CO 2 is the same as baseline after the step reduction inVA, and assuming the test phase is completed before re-circulation, these two Fick equations are solved forQ:
The DF avoids the difficulty of measuring P v CO 2 , however DF has acknowledged limitations. 11 T to attain its new equilibrium before re-circulation, a limitation that applies to all FickQ techniques.
11 15 16 Finally, measuring VCO 2 T is technically challenging. We address all three issues by introducing SGD and an iterative approach.
Sequential gas delivery
The core of the iterative method is the ability to precisely controlVA by using an SGD breathing circuit. 17 18 In brief, the SGD circuit is configured with a non-rebreathing valve, an expiratory gas reservoir, and an inspiratory gas reservoir supplied by a flow-controlled gas blender. A one-way valve between the expiratory gas reservoir and the inspiratory limb enables rebreathing of previously expired gas at the end of inspiration to the extent that minute ventilation exceeds fresh gas flow to the circuit. Because exhaled gas has already equilibrated with pulmonary blood, it provides no gradient for gas exchange, and is 'neutral'. The blender gas flow is the only gas potentially available for gas exchange, regardless of minute ventilation, and thereforeVA is equal to the blender gas flow, which is known precisely (to the accuracy of the gas blender).
[When the PCO 2 of the inspired gas is .0, the flow of inspired gas can be conceptually divided into fresh gas and 'neutral' gas:VA¼ total gas flow (1 − PI CO 2 /Pa CO 2 ).] 17 The partial pressure of CO 2 in inspired gas (PI CO 2 ) is also known from the gas blender settings, and PE 
Dividing by PB (barometric pressure corrected for the presence of water vapour) converts partial pressures into fractional concentrations. The important advantage of SGD for measuringQ is that first, it enables precise setting of alveolar ventilation (and thusVCO 2 ) through control of fresh gas flow. Secondly, to the extent that rebreathed gas enters alveolar dead space, it brings gas concentrations closer to those of normally perfused alveoli and reduces ventilation -perfusion heterogeneity in the lung, 19 enabling end-tidal gas to better reflect alveolar gas, 19 and arterial blood gas. 20 -23 As a result, sources of error for the parameters used to measureQ (VCO 2 B ,VCO 2 T , Pa CO 2 B , and Pa CO 2 T ) are reduced.
Iterative approach
We use an iterative approach to address the inability to establish a new equilibrium Pa CO 2 after a step change inVCO 2 T before re-circulation. After establishing a baseline steady state, PE ′ CO 2 is raised by an arbitrary amount (about 1.33 kPa; 10 mm Hg) by delivering a bolus of CO 2 during inspiration, and the resulting PE
at the level of PE subsequent three breaths of the test. PI CO 2 T is calculated by substituting equation (5a and b) into equation (4) T as it is this PCO 2 that we wish to clamp for the next three breaths.) BecauseQ is unknown, an estimate (Q E ) is substituted, and PI CO 2 T is computed. In the first iteration,Q E is guessed.
Note that all parameters, other thanQ E , on the right of equation (6b) T ) at this or any-
T is sufficient to calculateQ using the DF [equation (7)].
Also note there is no tidal volume or respiratory rate in equation (6) or (7); they are subsumed byVA, which is known precisely as it is equal to the blender gas flow to the SGD breathing circuit. will exponentially approach an equilibrium value determined by PI CO 2 T and the actualQ. Figure 1 illustrates the three circumstances where the estimatedQ is too high, correct, or too low. Executing this test repeatedly, and using the DF equation (7) to calculate the nextQ E to be used in equation (6b) convergesQ E to the actualQ.
Animal experiments
The study was approved by the institution's animal care committee and conducted according to the guidelines of the Canadian Council on Animal Care. TheQ measurements were made in seven Yorkshire pigs weighing 27-34 (mean 30) kg that were undergoing orthotopic liver transplantation as part of an independent research project. 24 We reasoned that if the method functioned correctly under these widely variant, dynamic conditions, it should be sufficiently robust for most other clinical disorders.
Instead of the SGD circuit, described above in terms of valves and reservoir bags, we used a 'virtual' SGD compatible with an anaesthesia machine or ICU ventilator circuit. The specially designed proprietary software sensed inspiratory flows and injected CO 2 in a pattern that simulated a physical SGD circuit, including the flow of fresh gas and the administration of neutral ('rebreathed') gas at end inspiration (see Supplementary Appendix SA for technical details). ). Electrocardiogram, non-invasive arterial pressure (AP), heart rate, and pulse oximetry monitoring commenced using an AS/3 monitor (Datex-Ohmeda, Helsinki, Finland).
Animal preparation
Anaesthesia induced with isoflurane (4-5%) using a large animal cone veterinary mask was maintained (after establishment of the airway) with isoflurane 1. or downwards (inverted triangles) in PETCO 2 T indicates overestimation or under-estimation ofQ, respectively. In any case, sufficient data have been generated to calculateQ by the DF equation [equation (7)].
The surgical techniques of OLT are described in detail elsewhere. 25 During the anhepatic phase, cross-clamping of the inferior vena cava (IVC), portal vein (PV), and hepatic artery was applied. A custom-made venous -venous bypass was used for venting the PV and IVC flows into the superior vena cava. The shunt consisted of an 8.5 Fr inflow cannula (Edwards Life Sciences) placed into the splenic vein and an 8.5 Fr outflow cannula inserted into the IJV contralateral to the PAC insertion. A 50 cm long tube connected the inflow and outflow cannulas. Blood was impelled through the bypass by the pressure gradient across the venous cross-clamps. Administration of fluids, vasoconstrictors, and inotropes was left to the discretion of the anaesthesia provider. Q TD was determined as the average of four sequential injections of 5 ml of iced (0-38C) normal saline into the right atrium port of the PAC. Fluid infusions were stopped beforeQ TD measurements. Only measurements with a proper thermodilution curve and with a variation ,20% between individual injections were included in the final analysis.Q IT measurements were commenced after initiation of mechanical ventilation and maintained thereafter every 90 s ( 80 s baseline, 12 s test). The performance of theQ IT tests was fully automated requiring no operator input. Because of a large metabolic release of CO 2 after sodium bicarbonate administration,Q IT measurements obtained within the next 5 min were excluded. TheQ IT measurement closest to the corresponding meanQ TD measurement was used for comparisons.
Statistical analysis
Statistical analyses were accomplished using commercial software (SigmaPlot 12.5, Systat Software, Germany). Results are expressed as mean [standard deviation (SD)] unless otherwise specified. Pairs ofQ TD andQ IT measurements were used to calculate a Pearson correlation coefficient, and the bias and limits of agreement by the method of Bland and Altman 26 modified for repeated measurements in the same subject. 27 28 Percentage error was calculated as 1.96 SD of the difference divided by the meanQ. 29 Trending ability ofQ IT to follow changes ofQ TD was determined using the half-circle polar plot method, after applying an exclusion zone radius of 15% of the meanQ. 30 An exponential function was fitted by the method of least squares toQ IT measurements obtained after acute changes ofQ (after IVC cross-clamping) to provide the time constant of convergence ofQ IT to the trueQ value.
Results
A total of 167 pairs of the meanQ TD and associatedQ IT measurements were acquired during the OLT experiments. Figure 2 presents allQ IT andQ TD measurements. OLT was accompanied by profound changes of haemodynamic parameters, especially during the anhepatic and reperfusion stages (Fig. 3) . The ranges ofQ TD andQ IT measurements for all animals were 0.6 -5.4 (mean 2.8) and 0. (Fig. 4) . The percentage error between was 32%. The half-circle polar plot showed a mean radial bias of 278 with an SD and 95% confidence interval of the polar angle of 178 and 338, respectively (Fig. 5) .
The rate of convergence of theQ IT measurement after an acute change inQ was computed after cross-clamping of the IVC and PV, accompanied by acute decrease inQ IT from 4.1 (0.8) to 1.7 (0.2) litre min 21 . The time constant of convergence was 1.2 (0.2) iterations, so 3 iterations (270 s) are required for 95% convergence. There was no relationship between the time constant of convergence and magnitude of change inQ IT (R 2 ¼0.1).
Discussion
The main finding of this proof-of-concept study was that the novel respiratory iterative monitorQ IT is capable of providing a fully automated, semi-continuous, non-invasive measurement ofQ.Q IT implementation is feasible and easily adaptable to the respiratory circuits of an anaesthesia machine or an ICU ventilator. In the extreme OLTexperiments in which profound shifts inQ and other physiological parameters affect the accuracy of bothQ IT andQ TD methods,Q IT displayed what would appear to be a clinically acceptable trending capability, albeit the percentage error (32%) barely exceeded the 30% limit, generally required to conclude thatQ TD andQ IT might be used interchangeably in this experimental model. After acute changes oḟ Q E ,Q E converges to the actualQ at a rate of about one time constant of equilibration per iteration, or 95% by the third iteration. Contrary to prior FickQ methods,Q IT is based on reliable measures of all required parameters. Pa CO 2 is derived from an accurate measure of PE ′ CO 2 equilibrated using SGD. SGD reduces ventilation-perfusion heterogeneity, 20 22 making
equal to Pa CO 2 within the error of measurement of each parameter in spontaneous breathing human subjects and in mechanically ventilated pigs with both normal and abnormal lungs.VCO 2 is calculated from precisely known values ofVA, which is equal to the fresh gas flow to the SGD circuit, and the PCO 2 of tidal gases. The previous limitation in obtaining an equilibration of respiratory gas with mixed venous gas before re-circulation occurs is addressed by an iterative approach that exponentially converges on the P v CO 2 -Q pairs with each succeeding iterations. The smaller the drift of the PE ′ CO 2 values during the four breaths of the test, the closer is theQ IT calculation to actualQ. When there is no drift, theQ IT calculation is theoretically equal to actualQ.
Unlike other FickQ,Q IT is able to assess the validity of the output of the algorithm. IfQ IT and actualQ converge, PE ′ CO 2 will be unchanged during the test phase, whileQ E values above or below the actualQ can be easily identified by an upward or downward drift in the PE ′ CO 2 tracing, respectively. Furthermore, the magnitude of drift indicates the magnitude of the discrepancy. at baseline or during the test phase would result in only 9-11% error in measuredQIT.) We found that baseline PE ′ CO 2 did not increase over time during these experiments. Nevertheless, the physiological effects of administrating multiple CO 2 boluses while performingQ IT must be addressed in further studies in models with normal and diseased lungs.
Limitations
We usedQ TD as a reference technique because it is considered the clinical 'gold standard' for measurement ofQ. Consequently,Q TD will be the reference method against whichQ IT will be validated in further clinical studies. However, we also appreciate that there are significant limitations in usingQ TD as a reference in the OLT experiments. OLT was accompanied by abrupt and profound changes in blood temperature because of the large surgical exposure, incomplete mixing of unheated blood from the venous -venous bypass with venous return, and rapid infusions of i.v. fluids. These shifts of temperature affect measurements ofQ TD . 31 We note that our experimental model did not include thoracotomy, and so we could not use an ultrasonic flow meter applied to the PA, which would be a better referenceQ technique.
As for all respiratory-based methods, the presence of severe lung disease can affectQ IT accuracy. Previous studies in dogs, 32 spontaneously breathing healthy humans, 17 22 and swine with lung disease 20 21 indicate that SGD markedly reduces the gra-
and Pa CO 2 and so mitigates this source of error. However, the validity ofQ IT for significant V/Q mismatch conditions should be confirmed in further studies. To calculateQ,Q IT requires maintenance of a constant PE ′ CO 2 during the test period, which also serves as self-verification of accuracy. However, the degree of such constancy is not measured objectively and it remains a qualitative measure. We suggest thatQ E has the greatest influence on the choice of the most effective PI CO 2 T , but we did not measure the effect of imprecision for measures of PCO 2 and other non-systematic factors on the determination ofQ IT .
Another limitation of any respiratory-based measurement ofQ is that blood flow that bypasses alveolar gas exchange is not measured. The validity ofQ IT in the presence of high shunt fraction and high V D /V T should therefore be addressed in studies using appropriate experimental models. For example, our experimental model did not include animals with highQ.
Lastly, this study was carried out in mechanically ventilated animals, and althoughQ IT is suitable for spontaneous ventilation (see Supplementary Appendix SB), it will need validation in further studies.
Conclusions
We describe a novel fully automated respiratory-based method to measure cardiac output,Q IT , which overcomes a number of limitations of previous approaches. Our proof-of-concept study in the challenging model of OLT found acceptable bias and agreement betweenQ IT and the referenceQ TD . While it provided a good estimation of cardiac output, it cannot be regarded as a reliable measurement until further evaluation experiments are performed.
Supplementary material
Supplementary material is available at British Journal of Anaesthesia online.
